Cohen Klingenstein LLC
Source: SEC Form 13F · as of Mar 2026Cohen Klingenstein LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $203.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$203.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 129,058 | $118.7M |
| JNJJOHNSON & JOHNSON | 127,994 | $31.3M |
| AMGNAMGEN INC | 31,270 | $11.0M |
| PMPhilip Morris International Inc | 43,679 | $7.2M |
| ABTABBOTT LABORATORIES | 49,435 | $5.1M |
| PFEPFIZER INC | 169,014 | $4.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 17,200 | $4.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 79,398 | $4.4M |
| ABBVAbbVie Inc. | 18,000 | $3.9M |
| GILDGILEAD SCIENCES, INC. | 20,700 | $2.9M |
| BMYBRISTOL MYERS SQUIBB CO | 47,559 | $2.9M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 6,000 | $2.7M |
| GMOptec International, Inc. | 25,000 | $1.9M |
| GEHCGE HealthCare Technologies Inc. | 10,859 | $773K |
| BIIBBIOGEN INC. | 4,000 | $733K |
| ZTSZoetis Inc. | 4,430 | $524K |
| VTRSViatris Inc | 18,354 | $248K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.